Literature DB >> 25840337

National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery.

Navneet S Majhail1, Lih-Wen Mau2, Pintip Chitphakdithai3, Tammy Payton2, Michael Eckrich4, Steven Joffe5, Stephanie J Lee6, Charles F LeMaistre7, Jennifer LeRademacher8, Fausto Loberiza9, Brent Logan8, Susan K Parsons10, Ramona Repaczki-Jones11, Pam Robinett2, J Douglas Rizzo12, Elizabeth Murphy2, Ellen M Denzen2.   

Abstract

Hematopoietic cell transplantation (HCT) is a complex procedure that requires availability of adequate infrastructure, personnel, and resources at transplantation centers. We conducted a national survey of transplantation centers in the United States to obtain data on their personnel, infrastructure, and care delivery models. A 42-item web-based survey was administered to medical directors of transplantation centers in the United States that reported any allogeneic HCT to the Center for International Blood and Marrow Transplant Research in 2011. The response rate for the survey was 79% for adult programs (85 of 108 centers) and 82% for pediatric programs (54 of 66 centers). For describing results, we categorized centers into groups with similar volumes based on 2010 total HCT activity (adult centers, 9 categories; pediatric centers, 6 categories). We observed considerable variation in available resources, infrastructure, personnel, and care delivery models among adult and pediatric transplantation centers. Characteristics varied substantially among centers with comparable transplantation volumes. Transplantation centers may find these data helpful in assessing their present capacity and use them to evaluate potential resource needs for personnel, infrastructure, and care delivery and in planning for growth.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Care delivery models; Hematopoietic cell transplantation; Infrastructure; Personnel; Survey; Transplantation center

Mesh:

Year:  2015        PMID: 25840337      PMCID: PMC4466059          DOI: 10.1016/j.bbmt.2015.03.020

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  8 in total

1.  The National Marrow Donor Program's symposium on patient advocacy in cellular transplantation therapy: addressing barriers to hematopoietic cell transplantation.

Authors:  Elizabeth A Murphy; Stacy Stickney Ferguson; Nancy Atieno Omondi; Lisa C Getzendaner; James L Gajewski; Gary A Goldstein; John R Wingard; J Douglas Rizzo; Navneet S Majhail; Navneet S Mahjail
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-30       Impact factor: 5.742

2.  Prevalence of hematopoietic cell transplant survivors in the United States.

Authors:  Navneet S Majhail; Li Tao; Christopher Bredeson; Stella Davies; Jason Dehn; James L Gajewski; Theresa Hahn; Ann Jakubowski; Steven Joffe; Hillard M Lazarus; Susan K Parsons; Kim Robien; Stephanie J Lee; Karen M Kuntz
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-30       Impact factor: 5.742

Review 3.  Allogeneic transplant physician and center capacity in the United States.

Authors:  Navneet S Majhail; Elizabeth A Murphy; Nancy A Omondi; Pam Robinett; James L Gajewski; C Fred LeMaistre; Dennis Confer; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-12       Impact factor: 5.742

4.  The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: a health care resource and infrastructure assessment.

Authors:  Navneet S Majhail; Elizabeth A Murphy; Ellen M Denzen; Stacy Stickney Ferguson; Stacy S Ferguson; Claudio Anasetti; Arthur Bracey; Linda Burns; Richard Champlin; Norman Hubbard; Miriam Markowitz; Richard T Maziarz; Erin Medoff; Joyce Neumann; Kim Schmit-Pokorny; Daniel J Weisdorf; Deborah S Yolin Raley; Jeffrey Chell; Edward L Snyder
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-14       Impact factor: 5.742

5.  Preparing for growth: current capacity and challenges in hematopoietic stem cell transplantation programs.

Authors:  Jeffrey R Schriber; Claudio Anasetti; Helen E Heslop; Alan K Leahigh
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-16       Impact factor: 5.742

6.  Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative.

Authors:  Ellen M Denzen; Navneet S Majhail; Stacy Stickney Ferguson; Claudio Anasetti; Arthur Bracey; Linda Burns; Richard Champlin; Jeffrey Chell; Helen Leather; Michael Lill; Richard T Maziarz; Erin Medoff; Joyce Neumann; Kim Schmit-Pokorny; Edward L Snyder; Laura Wiggins; Deborah S Yolin Raley; Elizabeth A Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-15       Impact factor: 5.742

7.  Impending challenges in the hematopoietic stem cell transplantation physician workforce.

Authors:  James L Gajewski; C Frederick LeMaistre; Samuel M Silver; Michael C Lill; George B Selby; Mary M Horowitz; J Douglas Rizzo; Helen E Heslop; Claudio Anasetti; Richard T Maziarz
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-23       Impact factor: 5.742

Review 8.  Access to hematopoietic cell transplantation in the United States.

Authors:  Navneet S Majhail; Nancy A Omondi; Ellen Denzen; Elizabeth A Murphy; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-28       Impact factor: 5.742

  8 in total
  16 in total

Review 1.  Optimizing Quality and Efficiency of Healthcare Delivery in Hematopoietic Cell Transplantation.

Authors:  Navneet S Majhail
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

Review 2.  Patient-centered care coordination in hematopoietic cell transplantation.

Authors:  Nandita Khera; Patricia Martin; Kristen Edsall; Anthony Bonagura; Linda J Burns; Mark Juckett; Olivia King; C Frederick LeMaistre; Navneet S Majhail
Journal:  Blood Adv       Date:  2017-08-22

3.  Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial.

Authors:  Areej El-Jawahri; Lara Traeger; Joseph A Greer; Harry VanDusen; Sarah R Fishman; Thomas W LeBlanc; William F Pirl; Vicki A Jackson; Jason Telles; Alison Rhodes; Zhigang Li; Thomas R Spitzer; Steven McAfee; Yi-Bin A Chen; Jennifer S Temel
Journal:  J Clin Oncol       Date:  2017-09-19       Impact factor: 44.544

4.  Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT.

Authors:  Bipin N Savani; Myriam Labopin; Nicolaus Kröger; Jürgen Finke; Gerhard Ehninger; Dietger Niederwieser; Rainer Schwerdtfeger; Donald Bunjes; Bertram Glass; Gerard Socié; Per Ljungman; Charles Craddock; Frédéric Baron; Fabio Ciceri; Norbert Claude Gorin; Jordi Esteve; Christoph Schmid; Sebastian Giebel; Mohamad Mohty; Arnon Nagler
Journal:  Haematologica       Date:  2016-03-11       Impact factor: 9.941

5.  Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.

Authors:  William A Wood; Ruta Brazauskas; Zhen-Huan Hu; Hisham Abdel-Azim; Ibrahim A Ahmed; Mahmoud Aljurf; Sherif Badawy; Amer Beitinjaneh; Biju George; David Buchbinder; Jan Cerny; Laurence Dedeken; Miguel Angel Diaz; Cesar O Freytes; Siddhartha Ganguly; Usama Gergis; David Gomez Almaguer; Ashish Gupta; Gregory Hale; Shahrukh K Hashmi; Yoshihiro Inamoto; Rammurti T Kamble; Kehinde Adekola; Tamila Kindwall-Keller; Jennifer Knight; Lalit Kumar; Yachiyo Kuwatsuka; Jason Law; Hillard M Lazarus; Charles LeMaistre; Richard F Olsson; Michael A Pulsipher; Bipin N Savani; Kirk R Schultz; Ayman A Saad; Matthew Seftel; Sachiko Seo; Thomas C Shea; Amir Steinberg; Keith Sullivan; David Szwajcer; Baldeep Wirk; Jean Yared; Agnes Yong; Jignesh Dalal; Theresa Hahn; Nandita Khera; Carmem Bonfim; Yoshiko Atsuta; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-19       Impact factor: 5.742

6.  Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant.

Authors:  B K Watkins; J Horan; B Storer; P J Martin; P A Carpenter; M E D Flowers
Journal:  Bone Marrow Transplant       Date:  2016-12-19       Impact factor: 5.483

Review 7.  National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.

Authors:  Shahrukh K Hashmi; Christopher Bredeson; Rafael F Duarte; Stephanie Farnia; Susan Ferrey; Courtney Fitzhugh; Mary E D Flowers; James Gajewski; Dennis Gastineau; Melissa Greenwald; Madan Jagasia; Patricia Martin; J Douglas Rizzo; Kimberly Schmit-Pokorny; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-03       Impact factor: 5.742

Review 8.  Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics.

Authors:  Sanghee Hong; Navneet S Majhail
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

9.  Geographic access to hematopoietic cell transplantation services in the United States.

Authors:  P L Delamater; J P Uberti
Journal:  Bone Marrow Transplant       Date:  2015-10-12       Impact factor: 5.483

10.  Willingness to Travel for Cellular Therapy: The Influence of Follow-Up Care Location, Oncologist Continuity, and Race.

Authors:  Zachary A K Frosch; Esin C Namoglu; Nandita Mitra; Daniel J Landsburg; Sunita D Nasta; Justin E Bekelman; Raghuram Iyengar; Carmen E Guerra; Marilyn M Schapira
Journal:  JCO Oncol Pract       Date:  2021-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.